- State Associations:
- AOMA – Arizona
- Faculty:
- Joseph Lillo
- Duration:
- 49 Minutes
- Expiration:
- Never expires.
Description
Objectives:
- Apply latest guidelines for the treatment of atherogenic dyslipidemia
- Manage treating residual risk in statin-controlled patients
- Distinguish how to risk stratify patients at cardiovascular risk
Dr. Joseph Lillo discloses he is a member of the Speakers’Bureau for Amgen, Amarin and KOWA.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Arizona Osteopathic Medical Association (AOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
GRIEVANCE POLICY: The AOMA strives to provide continuing medical education programs to fulfill the needs of the attendees and to meet the AOA Uniform Guidelines and AOA Accreditation Requirements. Comments, questions, or complaints should be forwarded to AOMA Executive Director Josephine Zammuto, by calling the AOMA Office at 602-266-6699 or by mail to AOMA, 1951 W. Camelback Rd., Suite 105, Phoenix, AZ 85015, or by email to [email protected]
